Revenue EXPLOSION Coming?, page-48

First 48 Last

Share
Profile

Follow
Investek

324 Posts.

94

23/06/21

15:39

Post #: 54020093
Share

Originally posted by PigsMightFly: ↑

If you understood the company you would realise this "golden goose" is actually just the proof-of-concept disease that shows the amazing safety of the clinuvel drug and at the same time gathers data and gives authorities confidence in the company and what other diseases they can potentially treat.

Scenesse actually treats EPP and vitiligo by providing an artificial suntan - exactly the same as Epitan.

This is where you are going to see the real BIG FARM OF GOLDEN GEESE when Clinuvel get approval for their existing drug to treat Vitiligo, XP, VP, OTRs (organ transplant recipients), skin cancer sufferers, Stroke victims (85% of 15 Million currently untreated) and with their OTC products for people who want solar protection and DNA repair - so pretty much everyone!

CUV have treated one stroke patient. It will take another five years for the trials and approval process. The realistic chances of success are only 5-10%.

Every new purpose will need separate clinical trials and approval.

Don't believe the hype. Alpha-MSH drugs have been ignored by Big Pharma for 40 years because they are not particularly useful.

Clinuvel has now achieved FDA, EMA, TGA and Israel market approval for their drug and very, very few Australian biotechs can boast anything like this achievement.

You totally fail to understand that it is far easier to get Orphan Drug status. They have lower barriers for safety and efficacy and a much more streamlined approval process.

Furthermore CUV is also very undervalued compared to comparison stocks like MSB, TLX and PNV who have similar or higher valuations despite not being profitable and just burning cash and they do not have the approvals that CUV has.

Total nonsense. Each of these companies operate in totally different sectors. They have absolutely nothing in common and can't be compared.

Expand

You know what, keep talking down the company, keep up the aggressive shorting, I might as well top up at lower prices.

You're not shorting but are you already short? and now trying to cover?

Anyway bring on $20 again, I'll be sure to take advantage of the buying opportunity

CUV Price at posting: $27.39 Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

FBR

FBR's robotic home construction tech passes first US early-stage structural compliance check

DUR

Duratec snags $76.5M in works from Woodside and Defence respectively - including spy network upgrade

GL1

Global Lithium latest hit by lithium downturn; shares fall -10% as Manna DFS paused

SDF

Steadfast Group sees $600M wiped off on resumed trades after Four Corners feature

FRB

Firebird snaffles Environmental Permit for Jinshi plant

There are more pages in this discussion • 90 more messages in this thread...

First 48 Last

Add CUV (ASX) to my watchlist

(20min delay)
Last $14.58		Change 0.025(0.17%)		Mkt cap ! $724.1M

Open	High	Low	Value	Volume
$14.60	$14.60	$14.32	$651.0K	44.93K

Buyers (Bids)

No.	Vol.	Price($)
9	212	$14.56

Sellers (Offers)

Price($)	Vol.	No.
$14.59	299	9

View Market Depth

No.	Vol.	Price($)
8	200	14.560
5	97	14.550
4	193	14.540
2	137	14.530
4	206	14.520

Price($)	Vol.	No.
14.590	232	8
14.600	837	4
14.610	85	2
14.620	71	2
14.630	50	3

Last trade - 15.19pm 10/09/2024 (20 minute delay)

CUV (ASX) Chart

Revenue EXPLOSION Coming?, page-48

FBR's robotic home construction tech passes first US early-stage structural compliance check

Duratec snags $76.5M in works from Woodside and Defence respectively - including spy network upgrade

Global Lithium latest hit by lithium downturn; shares fall -10% as Manna DFS paused

Steadfast Group sees $600M wiped off on resumed trades after Four Corners feature

Firebird snaffles Environmental Permit for Jinshi plant

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Revenue EXPLOSION Coming?, page-48

Top Stories

FBR's robotic home construction tech passes first US early-stage structural compliance check

Duratec snags $76.5M in works from Woodside and Defence respectively - including spy network upgrade

Global Lithium latest hit by lithium downturn; shares fall -10% as Manna DFS paused

Steadfast Group sees $600M wiped off on resumed trades after Four Corners feature

Firebird snaffles Environmental Permit for Jinshi plant

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News